The Blau Syndrome Market is navigating a transformative period as advancements in genetic research and orphan drug designations accelerate the development of targeted therapies. Characterized by a triad of granulomatous dermatitis, arthritis, and uveitis, this rare autoinflammatory disorder requires specialized, lifelong management to prevent systemic complications. https://www.databridgemarketresearch.com/